Meet our team
Andreas has experience from both clinical practice and research in health care. He is the founder of a medical simulation and training center for minimal invasive surgery at Karolinska University Hospital. Since 2004, Andreas has worked in financial markets, focusing on stock trading and was the founder and CEO of the electronic stock broker Spring Securities. He is a trained physicist and physiotherapist.
Malin has extensive experience in financial analysis of companies within life science and digital health. Previously, she was CFO at the stock brokerage firm Spring Securities, where she built up the company's finance and risk function. She has also worked as an analyst at the corporate finance company Billström & Mucher. Malin has a degree in economics from the Stockholm School of Economics, specializing in accounting and financial management.
Gunnar is a surgeon and earned his Ph.D. at Karolinska Institutet in Stockholm. He has 30 years of clinical and strategic experience in senior management positions in healthcare. He is the CEO of Kirurgkliniken Sophiahemmet, a board member of EAES, and a researcher at Karolinska Institutet. Formerly, Gunnar was Head of Business Development at Praktikertjänst, CEO of Sollentuna Specialistklinik, and Head of Department at Sabbatsberg Hospital.
Karl-Fredrik has solid experience in company development, financial modeling, and capital raising. He previously worked as an Investment Manager at Twig Ventures, focusing on investments in tech companies. Before that, he worked with M&A at Hjalmarsson & Partners and as an equity research analyst at Erik Penser Bank. Karl-Fredrik also has board experience from life science and digital health companies. He holds a master's degree from the Gothenburg School of Economics.
Teodora has performed experimental medical research for eight years. She holds a PhD in Medical Science from Karolinska Institutet, where she conducted cancer research, focusing on targeted therapies. Previously she studied biomedicine at Karolinska Institutet and medical innovation and entrepreneurship at Stockholm School of Entrepreneurship. In her spare time, she is active in Swedish Young Shareholders' Association, managing the association’s public portfolio.
Malin has many years of experience in private healthcare, where she has worked as a financial manager within Praktikertjänst and Aleris. In her role as a financial manager, in addition to overall financial responsibility, she has also worked with public procurement, project management, M&A, due diligence processes, and the implementation of new systems. Malin holds a bachelor's degree in business administration from Stockholm University.
Marketing & Communication Manager
Charlotte has extensive experience in language, communication, and marketing. She has worked with digital communication and brand building, from strategy and concept to production, in various industries. Charlotte most recently came from Framfot Business Coaching and worked before that as a Senior Copywriter at BabyBjörn, where she also was the Managing Editor of the company's multilingual online magazine.
Sofia Ström Bernad
Sofia has solid experience in media and communication. She has worked strategically and operationally with digital communication, journalism, public relations, and copywriting. Sofia has worked for several years in science communication at the Swedish Childhood Cancer Foundation and Linköping University and previously as a news journalist at TT and Svenska Dagbladet.
Back Office Manager
Christina has many years of experience in regulatory compliance and risk management and held most recently the position of Operational Compliance Officer at Aon. Prior to that, she was the Claims Manager for Aon Sweden’s health claims department responsible for claims management, insurance, and claims administration.
Daniel has worked in IT for twenty years and comes most recently from Stockholm University's IT Department. As System Administrator for the university’s knowledge base, he was responsible for integrations with ITSM and strategies for knowledge sharing and self-service. Daniel has also been the System Specialist for electronic elections to departments and faculty boards at the university.
External board members and advisors
Chairman of the Board
Erik is COO of KRY and an Advisory Board Member at Wistrand Advokatbyrå. He has many years of experience in media and IT management and was previously Head of Change Office at Schibsted Media Group, COO of Schibsted Sweden and a Board Member of, among others, Schibsted Growth, Svenska Dagbladet, Aftonbladet and Hitta.se. Erik holds a master's degree from Stockholm School of Economics.
Bengt is a pharmacist and began his career in the pharmaceutical industry in 1978 at Astra. During the 1980s, Bengt was the Nordic General Manager of Baxter Healthcare. Since 1990, he has been an active investor and Board Member of a variety of life science companies. Bengt is the chairman of the board of Linc AB, an investment company with holdings in, among others, Medivir, Calliditas Therapeutics, and Sedana Medical.
Thomas is an active business angel and investor in growth companies. He has a broad range of experience in the IT and finance sectors and was previously Head of Sales and Business Development at Aktietorget (now Spotlight) and Burgundy Oslo Börs, the founder of Exnet Transaction Services, Product Manager at Itiviti and Sales Manager at Sungard Financial Systems.
Sciety is an investment syndicate striving to make innovations reach their full potential. Our experienced and committed team also provides market analyses and investor relation services to companies within our segments.
Sciety AB (556990-3692) is regulated by Finansinspektionen and is a member of the Swedish Private Equity & Venture Capital Association (SVCA) and SwedenBIO (trade association for life science industry).
This is what our clients say
"I have invested in unlisted companies during a number of years. What I really appreciate with Sciety is that they very carefully consider my interests – from the first meeting to the completed investment. With Sciety, I feel confident that the relevant documents are in place and that I receive a very good decision-making basis for my investments."
Martin Öhrn, Private investor
"I can highly recommend Sciety. Their investor syndicate is very valuable to the high tech companies managed by SU Holding. We are, of course, also very pleased with the high return we received on our investment in EMPE Diagnostics."
Mona Wilcke, CEO of SU Holding
"The Sciety team is professional with a rare blend of expertise in life science, finance and entrepreneurship. Their network of investors is of great value for high tech companies such as Attana. Thanks to our fundraising with Sciety, we have also gained new, valuable competence in our board."
Teodor Aastrup, CEO of Attana
“Sciety offers a professional and structured way to access financing at an early stage. Life science projects are often difficult to analyse; therefore, Sciety’s focus on this segment is positive for both companies seeking financing and for investors looking for new investment possibilities.”
Fredrik Sjövall, CEO of Inhalation Sciences
"Sciety maintains an efficient process and provides solid experience in raising capital. We have received several competent and financially strong shareholders and for that we are very grateful."
Mats Hilmersson, CEO of Cavis Technologies
Why Life Science?
With challenges such as an aging population, life style and chronic illnesses, there is a major requirement for new forms of treatment and preventive measures. The industry is also characterised by an increasing degree of client awareness and cost efficiency. Today, we see new, interesting areas such as AI, precision medicines and remote healthcare growing very rapidly, creating the need of improved diagnostics, medical technology, digital platforms and new business models.
There are many prominent companies, researchers and clinics in Sweden developing today’s, and the future’s, healthcare and treatment solutions. We also see an increasing number of purchasers of new services and products –from healthcare providers and pharmacists to pharma and insurance companies, and from employers. Sciety sees a major investment potential in companies offering, new, effective solutions to healthcare providers in order that they can, in their turn, contribute to improved health for more people.